Transforming Pharmaceutical Research
MIT AI Models Fast-Track New Drug Discovery
Researchers at the Coley Lab deploy FlowER and ShEPhERD to identify drug candidates using generative AI.
A digital visualization of a complex molecular structure and chemical reaction pathways on a high-resolution laboratory monitor, representing MIT's new generative AI drug discovery models.
Photo: Avantgarde News
Researchers at the Massachusetts Institute of Technology developed AI tools to speed up medicine development. The Coley Lab at MIT released computational models called FlowER and ShEPhERD [1]. These systems analyze millions of chemical compounds to predict reaction pathways and evaluate how drugs interact with proteins [1].
Pharmaceutical companies are already using these tools to find small-molecule drug candidates [1]. Traditional experimental methods take much longer than these new digital simulations [1]. By applying chemical principles to generative AI, the team aims to make drug discovery more efficient [1].
Editorial notes
Transparency note
AI assisted drafting. Human edited and reviewed.
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
The story relies on a single source domain (MIT News), failing the requirement for three independent domains.
Sources
Related stories
View all
Topics
About the author
Avantgarde News Desk covers transforming pharmaceutical research and editorial analysis for Avantgarde News.